The key objective of EUKN is to enhance the exchange of knowledge and expertise on urban development throughout Europe, bridging urban policy, research, and practice. EUKN is characterised by a demand-driven approach, based on the needs of urban practitioners and policymakers. EUKN has developed an extensive, high-quality knowledge database, based on shared standards and protocols. This extensive e-library provides free access to case studies, research results, policy documents, context issues, network descriptions, updated news, and meetings. Over the past five years, EUKN has proven itself to be an efficient one-stop urban shop, providing city practitioners, policymakers, project managers, and other users with high-quality urban knowledge and experiences. At the same time, EUKN is more than a virtual knowledge network. It constitutes an international platform stimulating the exchange of knowledge and experiences during international and national meetings, and offering topical dossiers, expert opinions, and specific practical assistance through the National Focal Points of the network and support for EU Presidencies.

10X Genomics is creating revolutionary DNA sequencing technology to help researchers better identify subtle variations that are overlooked by technologies that shred biological samples into tiny fragments before sequencing the short stretches and using computers to assemble them into a genome.

20Med Therapeutics is a Dutch biomedical company active in the field of controlled drug delivery, developing and exploiting a portfolio of multifunctional polymer-based carriers for targeted delivery of small interfering RNAs (siRNAs) and microRNAs (miRNAs) for treatment of genetic diseases. The 20Med delivery technology is based on the development of a unique set of polymeric hybrid constructs (hereafter called 20Med-nanogels) which possess an unmet combination of properties essential for successful siRNA delivery in clinical applications. 20Med-nanogels are stable, well-processable, nontoxic, and biodegradable nanoparticles that can be stored as powder formulation and can be easily loaded with oligonucleotides after dissolution. Specific chemical functionalities within the 20Med-nanogel architecture promote endosomal escape and efficient release of the therapeutic payload into the cytosol after the nanoparticles are taken up by the cells, resulting in high transfection and gene silencing efficiencies. Moreover, due to their special chemical construction, 20Med nanogels are very flexible in tuning chemical functionalization and molecular architecture, which makes them also excellently suitable for developing tailor-made carriers for targeted delivery of therapeutic peptides, proteins, and small molecules.

42Workspace is the community hub for tech entrepreneurs in the heart of Rotterdam. Join their cowork hub and experience how a powerful community contributes to the growth of your company.

4cast is een onafhankelijk adviesbureau actief op het gebied van de modellering van verkeer en vervoer. Het ontwikkelen en toepassen van verkeersmodellen en het analyseren en duiden van de uitkomsten vormen de kerntaken van onze werkzaamheden. Hierbij worden zowel statische modellen als dynamische modellen ingezet. 4cast biedt via haar werknemers vele jaren ervaring op het gebied van het ontwikkelen, schatten, toepassen en beheren van complexe modelsystemen waaronder het Landelijk Model Systeem Verkeer en Vervoer en het Nieuw Regionaal Modelsysteem. In de achterliggende 15 jaar hebben wij onze kennis en ervaring veelvuldig toegepast op verschillende planologische schaalniveaus. Resultaten van onze studies zijn veelvuldig gebruikt bij de besluitvorming rondom infrastructurele ingrepen. Naast nationale en regionale beleidsvraagstukken richten wij ons ook op lokale en gemeentelijke inrichtingsstudies. Tot onze klantenkring behoren hoofdzakelijk nationale en regionale overheden, (openbaar) vervoerorganisaties en diverse advies- en ingenieursbureaus.

Aanmelder.nl develops software to bring people together at smart events.

ABB is a global technology leader in electrification and automation, enabling a more sustainable and resource-efficient future. By connecting its engineering and digitalization expertise, ABB helps industries run at high performance, while becoming more efficient, productive and sustainable so they outperform. At ABB, we call this ‘Engineered to Outrun’. The company has over 140 years of history and more than 105,000 employees worldwide. ABB’s shares are listed on the SIX Swiss Exchange (ABBN) and Nasdaq Stockholm (ABB). www.abb.com

ABB's E-Mobility division remotely diagnoses, cures infrastructure, and updates in-house developed software with EV charging technology.

ABB is a technology leader in electrification and automation, enabling a more sustainable and resource-efficient future. The company’s solutions connect engineering know-how and software to optimize how things are manufactured, moved, powered and operated. Building on over 140 years of excellence, ABB’s more than 110,000 employees are committed to driving innovations that accelerate industrial transformation.

Accuselect is the end-to-end service for home batteries in The Netherlands, with energy simulation software and a professional installer network.

Acoustic Insight develops medical devices designed to identify middle-ear abnormalities. Its device is based on Optical Coherence Tomography to otology for non-invasive structural and functional imaging of the middle ear.

Backed by top-notch research medical centers in The Netherlands, Deep Breath transforms gigabytes of chaotic ICU data into actionable insights for clinicians at the bedside. By analysing high-frequency data, we capture subtle but crucial changes in patients’ breathing patterns to provide personalised, safe ICU care to save lives. This helps reduce complications, increase comfort, and reduce excessive costs for healthcare. Winner of Responsible AI in Health Care Nomination.